Skip to main content

Table 5 Multivariate analysis of variables associated with FEV1(%) in individuals with PI*ZZ genotype in EARCO

From: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

Variables

FEV1(%)

All (n = 453)

Augmented (n = 157)

Non-augmented (n = 296)

Beta

95% CI

Beta

95% CI

Beta

95% CI

Age

− 0.366

− 0.543, − 0.189

NS

− 0.577

− 0.792, − 0.362

Sex (male)

− 10.414

− 15.087, − 5.741

− 13.460

− 20.283, − 6.638

− 8.004

− 14.006, − 2.003

Smokers

NS

NS

NS

Exacerbations

− 15.741

− 20.781, − 10.701

− 13.476

− 20.191, − 6.761

− 16.985

− 23.870, − 10.100

Pneumonia

NS

NS

NS

Blood eosinophils

NS

NS

NS

Blood neutrophils

− 0.060

− 0.092, − 0.027

NS

− 1.158

− 2.261, − 0.056

Serum AAT

27.077

22.949, 31.205

NS

NS

Platelets

− 0.565

− 0.859, − 0.125

NS

− 0.068

− 0.112, − 0.024

Augmentation

− 0.366

− 0.543, − 0.189

NS

NS

  1. AAT: alpha-1 antitrypsin; CI: Confidence interval; FEV1: Forced expiratory volume in 1 s; NS: non-significant